MedPath

Cortisol Response to Low Dose Cosyntropin Stimulation Test in the Late Afternoon

Not Applicable
Completed
Conditions
Adrenal Insufficiency
Interventions
Diagnostic Test: low-dose cosyntropin stimulation test
Registration Number
NCT03074123
Lead Sponsor
Bnai Zion Medical Center
Brief Summary

Previous study showed that afternoon cosyntropin testing was associated with a sevenfold increased likelihood of failing the 1μg test. However, in that study, investigators used a 20.3 cm plastic tube, which might have led to uncompleted cosyntropin delivery. In ther current study investigators will study afternoon 1μg cosyntropin cortisol stimulation using a short 2.5 cm tube.

Detailed Description

In earlier studies investigators claimed that subnormal cortisol response using plastic tubes might result from cosyntropin adherence to the tube and loss of the delivered dosage. It was shown that 21.6-58.6% of ACTH dosage had not been recovered when pushed through 20.3 cm plastic tube, and loss of ACTH may be up to 70% when cosyntropin was delivered through a plastic 30 cm scalp vein set.

Moreover, it was previously shown that afternoon cosyntropin testing was associated with a sevenfold increased likelihood of failing the 1μg test. However, in that study, investigators used a 20.3 cm plastic tube, which might have led to uncompleted cosyntropin delivery. In ther current study investigators will study afternoon 1μg cosyntropin cortisol stimulation using a short 2.5 cm tube.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

healthy volunteers

Exclusion Criteria

Clinical suspicion of hypoadrenalism Medical condition or treatment that might alter blood cortisol levels Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
healthy subjectslow-dose cosyntropin stimulation test20 healthy subjects will undergo low dose cosyntropin stimulation test. Serum and salivary cortisol will be measured just before cosyntropin administration and 30 minutes later.
Primary Outcome Measures
NameTimeMethod
Blood cortisolone day

Serum cortisol concentrations during intravenous low dose cosyntropin stimulation through short tube.

Secondary Outcome Measures
NameTimeMethod
Salivary free cortisolone day

Salivary free cortisol concentrations during intravenous low dose cosyntropin stimulation through short tube.

Trial Locations

Locations (1)

Mira Koch

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath